A carregar...

Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update

Hematopoietic cell transplant (HCT) can cure both children and adults with sickle cell disease. Outcomes have historically been poor for the vast majority of patients who lack a matched sibling donor. However, the development of haploidentical HCT (haplo-HCT) with high doses of posttransplant cyclop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hematol Oncol Stem Cell Ther
Main Authors: Patel, Dilan A., Akinsete, Adeseye M., de la Fuente, Josu, Kassim, Adetola A.
Formato: Artigo
Idioma:Inglês
Publicado em: King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7118612/
https://ncbi.nlm.nih.gov/pubmed/32202252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hemonc.2020.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!